LCID
Lucid Group, Inc.
LCID's outlook is improving, though it still trails on the overall score.
YUMC
Yum China Holdings, Inc.
YUMC has the edge over LCID overall, supported by lower modeled downside and stronger valuation.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
YUMC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Healthy |
YUMC's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
YUMC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 15x | $49.21 | — |
| Current | 17x | $49.21 | — |
| Cheap | 18x | $52.36 | +6.4% |
| Fair | 23x | $67.05 | +36% |
| Expensive | 32x | $92.59 | +88% |
Historical ranges are pointers, not guarantees.
YUMC's PE is in its cheap range at 17x. If earnings grow as analysts expect, today's price would be 15x next year's earnings.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
YUMC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for YUMC, with profitability improving.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
YUMC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.26 | +13% |
| Q3 2026 | $2.88 | +20% |
| Q2 2026 | $2.73 | +13% |
| Q1 2026 | $2.61 | +9.2% |
| Q4 2025 | $2.51 | +7.7% |
| Q3 2025 | $2.41 | +6.2% |
| Q2 2025 | $2.42 | +16% |
| Q1 2025 | $2.39 | +20% |
| Q4 2024 | $2.33 | +18% |
YUMC has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over YUMC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
YUMC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.5B | +8.5% |
| Q2 2026 | $3.1B | +13% |
| Q1 2026 | $3.3B | +9.7% |
| Q4 2025 | $2.8B | +8.8% |
| Q3 2025 | $3.2B | +4.4% |
| Q2 2025 | $2.8B | +4% |
| Q1 2025 | $3B | +0.8% |
| Q4 2024 | $2.6B | +4.1% |
YUMC's revenue has grown year over year for 15 quarters in a row: $3.5B last quarter, up 8.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 13% | +0.5 points |
| Q2 2026 | 11% | +0.2 points |
| Q1 2026 | 14% | +0.3 points |
| Q4 2025 | 6.6% | +0.8 points |
| Q3 2025 | 12% | +0.4 points |
| Q2 2025 | 11% | +1 points |
| Q1 2025 | 13% | +0.7 points |
| Q4 2024 | 5.8% | +1.4 points |
YUMC has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
YUMC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $359M | +2.3% |
| Q2 2026 | $299M | +3.1% |
| Q1 2026 | $406M | +29% |
| Q4 2025 | -$116M | -$101M |
| Q3 2025 | $351M | +44% |
| Q2 2025 | $290M | +25% |
| Q1 2025 | $315M | +25% |
| Q4 2024 | -$15M | +$57M |
YUMC has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
YUMC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.7% | -6M shares |
| 1 year | -7% | -26M shares |
| 3 years | -18% | -77M shares |
| 5 years | -21% | -92M shares |
| Available history | -12% | -45M shares |
YUMC has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $263M |
| Q2 2026 | $312M |
| Q1 2026 | $218M |
| Q4 2025 | $452M |
| Q3 2025 | $324M |
| Q2 2025 | $195M |
| Q1 2025 | $173M |
| Q4 2024 | $192M |
YUMC spent $1.2B buying back its own shares over the past year, up 41% from the year before.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
YUMC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | -0.2x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | -0.3x | Net Cash |
| Q3 2025 | -0.4x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.4x | Net Cash |
| Q4 2024 | -0.4x | Net Cash |
YUMC's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
YUMC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.0 | Neutral |
| Stochastic | 77.4 | Neutral |
YUMC's weekly RSI is 59 (neutral) and its Stochastic is 77 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
YUMC PE vs Consumer Cyclical Sector
| Metric | YUMC | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 18x | 5.2% below |
| PE % | 10 | 47 | 37 pts below |
YUMC is trading at 17x earnings, in line with the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
YUMC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.8 | 10% above |
| 20 week MA | $44.8 | 10% above |
| 50 week MA | $47.1 | 4.6% above |
| 100 week MA | $46.4 | 6.1% above |
| 200 week MA | $46.8 | 5.2% above |
YUMC has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
YUMC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.7 | $57.7 | +19% |
| 2021 | $57.7 | $48.2 | -16% |
| 2022 | $48.2 | $55.6 | +15% |
| 2023 | $55.6 | $42.4 | -24% |
| 2024 | $42.4 | $49.1 | +16% |
| 2025 | $49.1 | $49.1 | +0.1% |
| 2026 YTD | $49.1 | $49.2 | +0.1% |
YUMC has the edge over LCID on returns for 2026, with the stronger performance.